PRKCSH (Gene)

Synonyms:AGE-R2, ENTREZ:5589, G19P1, GIIB, HGNC:9411, MIM:177060, NM_001001329, NM_001289102, NM_001289103, NM_001289104, NM_001379608, NM_001379609, NM_002743, NP_001001329, NP_001276031, NP_001276032, NP_001276033, NP_001366537, NP_001366538, NP_002734, PCLD, PCLD1, PKCSH, PLD1, PRKCSH, VASAP-60, XM_011528130, XM_011528131, XM_011528132, XP_011526432, XP_011526433, XP_011526434, protein kinase C substrate 80K-H
Omim:OMIM:177060
Id:94ebb130-37cd-5e95-8ec4-aab41defe28b
Hgnc:HGNC:9411
Entrez:5589
Description:PRKCSH beta subunit of glucosidase II
This gene encodes the beta-subunit of glucosidase II, an N-linked glycan-processing enzyme in the endoplasmic reticulum. The encoded protein is an acidic phosphoprotein known to be a substrate for protein kinase C. Mutations in this gene have been associated with the autosomal dominant polycystic liver disease. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jan 2014]

Analyze

Data Distillery
CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View PRKCSH's neighborhood in the knowledge graph.

Playbook Workflow Builder
Playbook Workflow Builder: Gene-Centric Workflow

View Gene-Centric information about the gene from a pre-built PWB workflow. View the workflow with PRKCSH.

Gene Partnership Appyter
CFDE Gene-Centric Appyter

The CFDE Gene Centric Appyter Resolves and Displays Gene-Centric information from CFDE APIs. Execute the Appyter using PRKCSH.

Gene and Drug Landing Page Aggregator
GDLPA Landing Pages Links

The Gene and Drug Landing Page Aggregator (GDLPA) finds links to primary and secondary source information from CFDE and other resources. Discover landing pages for PRKCSH.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with PRKCSH.

Results found

Linked to

DISPLAY PER PAGE
This repository is under review for potential modification in compliance with Administration directives.